NCT07475611

Effectiveness of an Interactive Screen in the Rehabilitation of Neglect in Adults With Subacute Stroke: A Randomized Controlled Trial in Argentina.

ENROLLING BY INVITATION NA Last updated 16 March 2026

What this trial tests

NA trial testing Myro Interactive Screen (Tyromotion) as a tool for occupational therapy approach in patients with unilateral neglect in Stroke in 12 participants. Enrolling by invitation.

Timeline

1 October 2025

Primary endpoint
1 December 2026

1 May 2027

Quick facts

Lead sponsor	Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia
Phase	NA
Status	ENROLLING BY INVITATION
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	health services research
Enrollment	12
Start date	1 October 2025
Primary completion	1 December 2026
Estimated completion	1 May 2027
Sites	1 location across Argentina

Drugs / interventions tested

• Myro Interactive Screen (Tyromotion) as a tool for occupational therapy approach in patients with unilateral neglect
• occupational therapy conventional treatment

Conditions studied

• Stroke — all drugs for Stroke →
• Neglect, Hemispatial — all drugs for Neglect, Hemispatial →

Sponsor

Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia

Who can join

Adults 18 to 88, any sex, with Stroke or Neglect, Hemispatial. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hemispatial neglect is one of the most frequent and disabling sequelae after a stroke, particularly following right-hemisphere lesions. Its prevalence ranges from 25% to 80% and is associated with poorer functional outcomes, increased risk of falls, prolonged hospital stays, and lower rates of discharge to home. In response to these challenges, rehabilitation technologies have emerged as promising tools, especially during the subacute phase of stroke, a critical period for neuroplasticity. The MYRO® device-an adjustable interactive screen that enables intensive, task-oriented training-has shown benefits in promoting visual scanning, midline crossing, and sensorimotor integration through personalized exercises with constant feedback.

This study aims to evaluate the effectiveness of MYRO® combined with conventional occupational therapy in patients with left hemispatial neglect secondary to subacute stroke. A randomized clinical trial will be conducted with 30 participants assigned to two groups: conventional occupational therapy (OT-C) and occupational therapy plus rehabilitation technology using MYRO® (OT-M). Both groups will receive interventions for four weeks, with assessments at baseline, at the end of the protocol, and at a six-week follow-up. Outcome measures will include the NIHSS, FIM, Catherine Bergego Scale, Cancelation Bells Test, and Line Bisection Test.

It is expected that the use of MYRO® will enhance visuospatial attention toward the left hemifield and accelerate functional recovery compared with conventional treatment alone. The results could provide relevant evidence supporting the integration of interactive technology into neurofunctional rehabilitation within the Argentine context.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.